Agouron Pharmaceuticals Inc.

Company Information

Company Name
Agouron Pharmaceuticals Inc.
Address
505 Coast Blvd
La Jolla, CA, 92037
Phone
n/a
URL
n/a
DUNS
n/a
Number of Employees
28
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$300,000.00
6
SBIR Phase II
$900,000.00
2

Award List

  1. IMMUNOLOGICAL AND DNA HYBRIDIZATION ASSAYS WHICH EMPLOY SPECIFIC ANTIBODY AND DNA PROBES ARE PROVING TO BE VERY VALUABLE IN THE IDENTIFICATION OF PATHOGENS AND IN THE DIAGNOSIS OF GENETIC DISEASES.

    Amount: $50,000.00

    IMMUNOLOGICAL AND DNA HYBRIDIZATION ASSAYS WHICH EMPLOY SPECIFIC ANTIBODY AND DNA PROBES ARE PROVING TO BE VERY VALUABLE IN THE IDENTIFICATION OF PATHOGENS AND IN THE DIAGNOSIS OF GENETIC DISEASES. TH ...

    SBIR Phase I 1985 Department of Health and Human Services
  2. DEVELOPMENT OF DIAGNOSTIC PROBES FOR AUTOIMMUNE DISEASE

    Amount: $400,000.00

    A CHARACTERISTIC FEATURE OF MANY RHEUMATIC DISEASES IS THE PRESENCE OF CIRCULATING ANTINUCLEAR ANTIBODIES. ASSAYS BASED ON THE MEASUREMENT OF THESE ANTIBODIES ARE ESTABLISHED IN THE CLINICAL LABORATOR ...

    SBIR Phase II 1988 Department of Health and Human Services
  3. MAJOR OBJECTIVES OF THIS RESEARCH ARE TO (1) ISOLATE 100 MG OF HOMOGENEOUS DIHYDROFOLATE REDUCTASE (DHFR) FROM CANDIDA ALBICANS, (2) CRYSTALLIZE THE ENZYME, AND (3) DETERMINE ITS THREE-DIMENSIONAL STRUCTURE USING X-RAY DIFFRACTION METHODS.

    Amount: $50,000.00

    MAJOR OBJECTIVES OF THIS RESEARCH ARE TO (1) ISOLATE 100 MG OF HOMOGENEOUS DIHYDROFOLATE REDUCTASE (DHFR) FROM CANDIDA ALBICANS, (2) CRYSTALLIZE THE ENZYME, AND (3) DETERMINE ITS THREE-DIMENSIONAL STR ...

    SBIR Phase I 1986 Department of Health and Human Services
  4. MAJOR OBJECTIVES OF THIS RESEARCH ARE TO (1) ISOLATE 100 MG OF HOMOGENEOUS DIHYDROFOLATE REDUCTASE (DHFR) FROM PSEUDOMONAS AERUGINOSA, (2) CRYSTALLIZE THE ENZYME, AND (3) DETERMINE ITS THREE-DIMENSIONAL STRUCTURE USING X-RAY DIFFRACTION METHODS.

    Amount: $50,000.00

    MAJOR OBJECTIVES OF THIS RESEARCH ARE TO (1) ISOLATE 100 MG OF HOMOGENEOUS DIHYDROFOLATE REDUCTASE (DHFR) FROM PSEUDOMONAS AERUGINOSA, (2) CRYSTALLIZE THE ENZYME, AND (3) DETERMINE ITS THREE-DIMENSION ...

    SBIR Phase I 1986 Department of Health and Human Services
  5. RETARDATION

    Amount: $50,000.00

    THIS PROJECT DESCRIBES THE ISOLATION OF DNA PROBES LINKED TOTHE SITE IN THE HUMAN X CHROMOSOME INVOLVED IN FRAGILITY OF THE CHROMOSOME UNDER SOME GROWTH CONDITIONS ("FRAGILE X SITE") AND KNOWN TO BE A ...

    SBIR Phase I 1986 Department of Health and Human Services
  6. SITE-DIRECTED DRUG DESIGN AGAINST PLASMODIUM FALCIPARUM.

    Amount: $500,000.00

    THE ULTIMATE OBJECTIVE OF THIS PROJECT IS TO UTILIZE THE INFORMATION AVAILABLE IN THE THREE-DIMENSIONAL CRYSTAL STRUCTURE OF AN ENZYME IN THE RATIONAL DESIGN OF DRUGS WHICHWILL BE EFFECTIVE AGAINST PL ...

    SBIR Phase II 1989 Department of Health and Human Services
  7. DEVELOPMENT OF DIAGNOSTIC PROBES FOR AUTOIMMUNE DISEASE

    Amount: $50,000.00

    N/A

    SBIR Phase I 1985 Department of Health and Human Services
  8. SITE-DIRECTED DRUG DESIGN AGAINST PLASMODIUM FALCIPARUM.

    Amount: $50,000.00

    N/A

    SBIR Phase I 1988 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government